search
Back to results

Consultation at 8 Days to Reduce Hospitalisations in Heart Failure Patient (CHIC)

Primary Purpose

Acute Heart Failure

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Follow-up
Sponsored by
Assistance Publique - Hôpitaux de Paris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Acute Heart Failure focused on measuring Acute heart failure; rehospitalisation; education; follow-up

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Criteria of inclusion :

  • Patient with decompensated heart failure hospitalized in the hospital BICHAT,
  • For whom is planned a return at home,
  • Valid (being able to return for a consultation to the hospital)
  • Having Nt-ProBNP of exit ≥ 3500 ng /l and/or a non optimized treatment of exit - according to the doctor who has it the responsibility,
  • Having signed the consent form by participation in the study.

Criteria of not inclusion :

  • Age < 18 years,
  • Not membership in a national insurance scheme or in the Universal Health
  • Coverage (CMU)(FREE UNIVERSAL HEALTH CARE)(A patient benefiting from the Medical aid of the State (AME) cannot be included)
  • Participation to another protocol of research,
  • Not being reachable by telephone in 6 months.

Sites / Locations

  • Hopital Bichat Claude Bernard

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control

Follow-up

Arm Description

usual care without systematic cardiology evaluation between 1 and 2 weeks

Evaluation by a cardiologist using echocardiography, completed by education of the patient if necessary

Outcomes

Primary Outcome Measures

days alive out of hospital 6 months post discharge

Secondary Outcome Measures

rehospitalisation rate at 6 months
mortality at 3 and 6 months
number of patients receiving beta-blocker at 6 months
number of patients receiving a ACEI at 6 months
QOL at 6 months
autoevaluation of improvement/alteration of the patient state at 6 months
number of patients receiving beta-blocker at 3 months
number of patients receiving a ACEI at 3 months
QOL at 3 months
autoevaluation of improvement/alteration of the patient state at 3 months
number of patients having an optimal treatment at 6 months
number of patients having an optimal treatment at 3 months

Full Information

First Posted
January 17, 2013
Last Updated
October 22, 2018
Sponsor
Assistance Publique - Hôpitaux de Paris
search

1. Study Identification

Unique Protocol Identification Number
NCT01834833
Brief Title
Consultation at 8 Days to Reduce Hospitalisations in Heart Failure Patient
Acronym
CHIC
Official Title
Consultation at 8 Days to Reduce Hospitalisations in Heart Failure Patient.
Study Type
Interventional

2. Study Status

Record Verification Date
October 2018
Overall Recruitment Status
Completed
Study Start Date
May 2013 (Actual)
Primary Completion Date
April 2017 (Actual)
Study Completion Date
July 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Evaluate the benefit of systematic appointment with a cardiologist a week after hospitalisation for acute heart failure. Randomised, endpoint: number of day alive out of hospital during 6 months
Detailed Description
Background: the risk for rehospitalisation is very high after hospitalisation for acute heart failure. Aim: evaluate the benefit of a consultation with a cardiologist, including echocardiography and education of the patient, between 7 and 15 days after discharge, in high risk patients, identified with BNP or incomplete therapy. Parallel randomised study. The main endpoint is the number of day alive out of hospital during the 6 months post discharge; statistics intention to treat comparison of the number of days alive out of hospital in the group with consultation compared with the group without consultation. Recruitment 3 years and 4 months, follow-up 6 months. Patients included have been hospitalised in hospital BICHAT 75018 Paris, France. Financing is by the ministry of health (PHRQHOS)

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Heart Failure
Keywords
Acute heart failure; rehospitalisation; education; follow-up

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
326 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
No Intervention
Arm Description
usual care without systematic cardiology evaluation between 1 and 2 weeks
Arm Title
Follow-up
Arm Type
Experimental
Arm Description
Evaluation by a cardiologist using echocardiography, completed by education of the patient if necessary
Intervention Type
Other
Intervention Name(s)
Follow-up
Intervention Description
Evaluation by a cardiologist using echocardiography, completed by education of the patient if necessary
Primary Outcome Measure Information:
Title
days alive out of hospital 6 months post discharge
Time Frame
6 months
Secondary Outcome Measure Information:
Title
rehospitalisation rate at 6 months
Time Frame
6 months
Title
mortality at 3 and 6 months
Time Frame
3 and 6 months
Title
number of patients receiving beta-blocker at 6 months
Time Frame
6 months
Title
number of patients receiving a ACEI at 6 months
Time Frame
6 months
Title
QOL at 6 months
Time Frame
6 months
Title
autoevaluation of improvement/alteration of the patient state at 6 months
Time Frame
6 months
Title
number of patients receiving beta-blocker at 3 months
Time Frame
3 months
Title
number of patients receiving a ACEI at 3 months
Time Frame
3 months
Title
QOL at 3 months
Time Frame
3 months
Title
autoevaluation of improvement/alteration of the patient state at 3 months
Time Frame
3 months
Title
number of patients having an optimal treatment at 6 months
Time Frame
6 months
Title
number of patients having an optimal treatment at 3 months
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Criteria of inclusion : Patient with decompensated heart failure hospitalized in the hospital BICHAT, For whom is planned a return at home, Valid (being able to return for a consultation to the hospital) Having Nt-ProBNP of exit ≥ 3500 ng /l and/or a non optimized treatment of exit - according to the doctor who has it the responsibility, Having signed the consent form by participation in the study. Criteria of not inclusion : Age < 18 years, Not membership in a national insurance scheme or in the Universal Health Coverage (CMU)(FREE UNIVERSAL HEALTH CARE)(A patient benefiting from the Medical aid of the State (AME) cannot be included) Participation to another protocol of research, Not being reachable by telephone in 6 months.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Guillaume JONDEAU, MD, PHD
Organizational Affiliation
Assistance Publique - Hôpitaux de Paris
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hopital Bichat Claude Bernard
City
Paris
ZIP/Postal Code
75018
Country
France

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Consultation at 8 Days to Reduce Hospitalisations in Heart Failure Patient

We'll reach out to this number within 24 hrs